Clear Discrepancy in Neurofibromin Expression between NF1 Pheochromocytoma Cells and Non-Tumorous Adrenal Medullary Cells
- 1 Department of Urology, Kanto Rosai Hospital, Kawasaki, Japan
- 2 Department of Urology, Kanto Rosai Hospital, Kawasaki, Japan
- 3 Department of Urology, Kanto Rosai Hospital, Kawasaki, Japan
- 4 Department of Pathology, Kanto Rosai Hospital, Kawasaki, Japan
- 5 Department of Pathology, Kanto Rosai Hospital, Kawasaki, Japan
- 6 Department of Pathology, Kanto Rosai Hospital, Kawasaki, Japan
- 7 Department of Pathology, Kanto Rosai Hospital, Kawasaki, Japan
- 8 Department of Urology, Kanto Rosai Hospital, Kawasaki, Japan
Abstract
Neurofibromatosis type 1 (NF1) is a common inherited disorder with an autosomal dominant trait. We encountered an NF1 patient who showed adrenal pheochromocytoma, and analyzed expression of neurofibromin in an excised specimen. A 54-year-old man showing multiple neurofibromas and café-au-lait spots in the skin was pointed out to have a right adrenal tumor by ultrasonography. Abdominal CT also revealed a right adrenal tumor. He was diagnosed with neurofibromatosis type 1 with no family history. Urine catecholamines, metanephrine, and normetanephrine levels were elevated. MIBG scintigraphy showed positive right adrenal uptake, and so pheochromocytoma was also diagnosed. The patient underwent laparoscopic right adrenalectomy. The excised adrenal specimen of this patient was stained with anti-neurofibromin polyclonal antibody. The NF1 pheochromocytoma was completely negative for neurofibromin protein expression, while the NF1 non-pheochromocytomatous adrenal medulla was neurofibromin-positive in the cytoplasm and nucleus. The clear discrepancy in neurofibromin expression between pheochromocytoma cells and “normal” adrenal medullary cells of the patient may well be explained by Knudson’s two-hit hypothesis.
- Theos, A. and Korf, B.R. (2006) Pathophysiology of Neurofibromatosis Type 1. Annals of Internal Medicine, 144, 842-849. http://dx.doi.org/10.7326/0003-4819-144-11-200606060-00010
- (1988) National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Archives of Neurology, 45, 575-578.
- Laycock-van Spyk, S., Thomas, N., Cooper, D.N. and Upadhyaya, M. (2011) Neurofibromatosis Type 1-Associated Tumours: Their Somatic Mutational Spectrum and Pathogenesis. Human Genomics, 5, 623-690. http://dx.doi.org/10.1186/1479-7364-5-6-623
- Kolackov, K., Tupikowski, K. and Bednarek-Tupikowska, G. (2012) Genetic Aspects of Pheochromocytoma. Advances in Clinical and Experimental Medicine, 21, 821-829.
- Welander, J., Soderkvist, P. and Gimm, O. (2013) The NF1 Gene: A Frequent Mutational Target in Sporadic Pheochromocytomas and Beyond. Endocrine-Related Cancer, 20, C13-C17. http://dx.doi.org/10.1530/ERC-13-0046
- Harrisingh, M.C. and Lloyd, A.C. (2004) Ras/Raf/ERK Signalling and NF1. Cell Cycle, 3, 1255-1258. http://dx.doi.org/10.4161/cc.3.10.1182
- Le, L.Q. and Parada, L.F. (2007) Tumor Microenvironment and Neurofibromatosis Type I: Connecting the GAPs. Oncogene, 26, 4609-4616. http://dx.doi.org/10.1038/sj.onc.1210261
- Snajderova, M., Riccardi, V.M., Petrak, B., Zemkova, D., Zapletalova, J., Mardesic, T., Petrakova, A., Lanska, V., Marikova, T., Bendova, S., Havlovicova, M. and Kaluzova, M. (2012) The Importance of Advanced Parental Age in the Origin of Neurofibromatosis Type 1. American Journal of Medical Genetics Part A, 158A, 519-523. http://dx.doi.org/10.1002/ajmg.a.34413
- Bunin, G.R., Needle, M. and Riccardi, V.M. (1997) Paternal Age and Sporadic Neurofibromatosis 1: A Case-Control Study and Consideration of the Methodological Issues. Genetic Epidemiology, 14, 507-516. http://dx.doi.org/10.1002/(SICI)1098-2272(1997)14:5 3.0.CO;2-Y
- Berger, A.H., Knudson, A.G. and Pandolfi, P.P. (2011) A Continuum Model for Tumour Suppression. Nature, 476, 163-169. http://dx.doi.org/10.1038/nature10275
- Walther, M.M., Herring, J., Enquist, E., Keiser, H.R. and Linehan, W.M. (1999) von Recklinghausen’s Disease and Pheochromocytomas. The Journal of Urology, 162, 1582-1586. http://dx.doi.org/10.1016/S0022-5347(05)68171-2
- Gutmann, D.H., Cole, J.L., Stone, W.J., Ponder, B.A. and Collins, F.S. (1994) Loss of Neurofibromin in Adrenal Gland Tumors from Patients with Neurofibromatosis Type 1. Genes, Chromosomes and Cancer, 10, 55-58. http://dx.doi.org/10.1002/gcc.2870100109